Shares of Abcam plc (LON:ABC – Get Free Report) were up 11.2% on Thursday . The stock traded as high as GBX 1,259 ($16.06) and last traded at GBX 1,226 ($15.64). Approximately 6,372,291 shares changed hands during mid-day trading, an increase of 1,522% from the average daily volume of 392,791 shares. The stock had previously closed at GBX 1,103 ($14.07).
Abcam Trading Up 11.2 %
The company has a market cap of £2.81 billion and a price-to-earnings ratio of 20,433.33. The firm has a 50 day moving average price of GBX 1,226 and a two-hundred day moving average price of GBX 1,226. The company has a quick ratio of 0.89, a current ratio of 1.27 and a debt-to-equity ratio of 31.60.
Abcam Company Profile
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools.
Read More
- Five stocks we like better than Abcam
- Which Wall Street Analysts are the Most Accurate?
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- What Are Dividend Achievers? An Introduction
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- Stock Average Calculator
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Abcam Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam and related companies with MarketBeat.com's FREE daily email newsletter.
